Search Results - "de Castro, E. Martínez"
-
1
TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM)
Published in Clinical & translational oncology (01-08-2020)Get full text
Journal Article -
2
Key points to optimizing management and research on cancer-associated thrombosis
Published in Clinical & translational oncology (01-02-2018)“…Despite the fact that thromboembolism is relatively common in oncology patients and that the interrelationship between thrombotic risk and specific mechanisms…”
Get full text
Journal Article -
3
Utility of Liquid Biopsy for Molecular Profiling and Monitoring in Metastatic Colorectal Cancer: A Pilot Study in a Real-World Cohort
Published in Journal of Liquid Biopsy (01-11-2023)Get full text
Journal Article -
4
PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy
Published in Thrombosis research (01-04-2016)“…Background Venous thromboembolism (VTE) is one of the major causes of cancer-associated mortality. Risk for developing VTE increases when in chemotherapy,…”
Get full text
Journal Article -
5
PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting
Published in Thrombosis research (01-04-2016)“…Introduction The incidence of thrombosis associated with pancreatic cancer chemotherapy is high (22-36%), however the incidence in BDT is unknown. Table 1…”
Get full text
Journal Article -
6
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
Published in ESMO open (01-06-2022)“…Recommendations for research articles include the use of the term sex when reporting biological factors and gender for identities or psychosocial or cultural…”
Get full text
Journal Article -
7
4CPS-123 Role of docetaxel in combination with cisplatin and capecitabine in advanced gastric cancer
Published in European journal of hospital pharmacy. Science and practice (01-03-2018)“…BackgroundAdvanced gastric cancer (AGC) does not have a chemotherapy regimen accepted as standard. Docetaxel has demonstrated benefits associated with…”
Get full text
Journal Article -
8
-
9
1823P Characterization of thrombosis risk in patients with cancer: Preliminary results
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
10
-
11
PO-61 Venous thromboembolic disease in cancer patients treated with immunotherapy: analysis of the TESEO study
Published in Thrombosis research (01-04-2021)Get full text
Journal Article -
12
585P - POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers
Published in Annals of oncology (01-10-2019)“…Biomarkers associated to antiangiogiogenic agents in metastatic colorectal cancer (mCRC) have not yet been validated Here we present the efficacy and safety…”
Get full text
Journal Article -
13
-
14
-
15
1754O - Prediction of serious complications in patients with cancer and pulmonary embolism: Validation of the EPIPHANY index in a prospective cohort of patients from the PERSEO study
Published in Annals of oncology (01-10-2019)“…The EPIPHANY decision tree is the first algorithm developed to predict serious complications in patients with cancer and pulmonary embolism (PE) (PMID:…”
Get full text
Journal Article -
16
1754OPrediction of serious complications in patients with cancer and pulmonary embolism: Validation of the EPIPHANY index in a prospective cohort of patients from the PERSEO study
Published in Annals of oncology (01-10-2019)“…Abstract Background The EPIPHANY decision tree is the first algorithm developed to predict serious complications in patients with cancer and pulmonary embolism…”
Get full text
Journal Article -
17
585PPOLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers
Published in Annals of oncology (01-10-2019)“…Abstract Background Biomarkers associated to antiangiogiogenic agents in metastatic colorectal cancer (mCRC) have not yet been validated Here we present the…”
Get full text
Journal Article -
18
-
19
PB0931 Long-Term Performance of a Clinical-Genetic Risk Score of Venous Thromboembolism (VTE) in Cancer Patients
Published in Research and practice in thrombosis and haemostasis (01-10-2023)Get full text
Journal Article -
20